|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product | |||||
| Service | |||||
| Distribution rights | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Product | |||||
| Service | |||||
| Total cost of revenue | |||||
| Gross profit (loss) | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Impairment charges | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income (expense), net | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss attributable to common stockholders, basic and diluted | |||||
| Amortization of beneficial conversion feature related to Series A convertible preferred stock | |||||
| Net loss per share, basic (USD per share) | |||||
| Net loss per share, diluted (USD per share) | |||||
| Weighted-average common shares used in computing net loss per share, diluted (in shares) | |||||
| Weighted-average common shares used in computing net loss per share, basic (in shares) |
Loading...